Welcome to our dedicated page for Healthstream SEC filings (Ticker: HSTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Scrolling through HealthStream’s 10-K and 10-Q can feel daunting—especially when you’re hunting for recurring SaaS subscription revenue, segment breakouts between Workforce and Provider Solutions, or acquisition costs buried in footnotes. If you’ve ever Googled “How do I read HealthStream’s annual report 10-K?� or searched for “HealthStream SEC filings explained simply,� this page was built for you.
Stock Titan captures every submission the moment it appears on EDGAR and delivers AI-powered summaries that remove the jargon. That means “understanding HealthStream SEC documents with AI� is finally practical. Need the latest “HealthStream quarterly earnings report 10-Q filing� or a quick brief on “HealthStream 8-K material events explained�? You’ll find them here, alongside plain-English insights into deferred revenue swings, segment margins, and hospital subscriber growth. Our engine also pulls highlights from the “HealthStream proxy statement executive compensation,� connecting CEO bonus metrics to quality-of-care benchmarks.
Governance watchers can follow real-time “HealthStream insider trading Form 4 transactions� without sifting through separate PDFs. Every “HealthStream executive stock transactions Form 4� is tagged, charted, and paired with peer comparisons so you can see buying or selling trends before the market reacts. Whether you want alerts on “HealthStream Form 4 insider transactions real-time,� a digest of “HealthStream earnings report filing analysis,� or a deep dive into the “HealthStream annual report 10-K simplified,� Stock Titan turns dense disclosures into decision-ready knowledge—fast.
Savers Value Village, Inc. (SVV) � Form 144 filing
An affiliated seller (Mindy Geisser) intends to sell 7,824 common shares through Fidelity Brokerage on or about 04 Aug 2025 on the NYSE. At the cited market value of US$89.8k, the proposed sale equals roughly 0.005 % of the 155.6 m shares outstanding, so float impact is immaterial. The shares derive from an option granted 12 Jun 2019 and exercised 04 Aug 2025 for cash.
The same insider sold 52,176 shares during the last three months, realizing US$566.2k in gross proceeds (48,000 sh on 03 Jul 2025 and 4,176 sh on 01 Aug 2025). Under Rule 144 the filer attests to possessing no undisclosed adverse information and, if using a 10b5-1 plan, to compliance as of the adoption date.
Although the volume is modest relative to SVV’s float, the continuing pattern of insider disposals can influence sentiment and merits monitoring by investors tracking governance and trading activity.